TrialArthritis care & research2014

Effect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter study.

D Gladman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.